Related Experiment Video

Updated: May 22, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

Knockdown of Cdc25B in renal cell carcinoma is associated with decreased malignant features

Xiu-Yue Yu1, Zhe Zhang, Guo-Jun Zhang

  • 1Department of Urology, The First Hospital of China Medical University, Shenyang, China.

Asian Pacific Journal of Cancer Prevention : APJCP
|May 29, 2012
PubMed

Insights

Cdc25B phosphatase is overexpressed in renal cell carcinoma, promoting tumor growth and progression. Inhibiting Cdc25B slowed cancer cell growth and invasion, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Medicine

Background:

  • Cdc25 phosphatases regulate the cell cycle.
  • Dysregulation of Cdc25 phosphatases is implicated in various cancers.
  • The specific role of Cdc25B in renal cell carcinoma (RCC) is not well understood.

Purpose of the Study:

  • To investigate the expression and role of Cdc25B in renal cell carcinoma development and progression.
  • To explore the potential of Cdc25B as a therapeutic target in RCC.

Main Methods:

  • Real-time RT-PCR and Western blotting were used to examine Cdc25B expression in RCC and normal tissues.
  • Cdc25B expression levels were correlated with clinical stage and histopathologic grade.
  • Cdc25B was knocked down using siRNA in 769-P cells to assess its functional impact.

Main Results:

  • Cdc25B expression was significantly higher in RCC tissues compared to normal tissues.
  • Elevated Cdc25B levels correlated positively with advanced clinical stage and higher histopathologic grade.
  • Cdc25B knockdown led to reduced cell growth, increased G2/M phase arrest, diminished migration and invasion, and induced apoptosis.
  • Cdc25B knockdown was associated with reduced expression of 14-3-3 protein.

Conclusions:

  • Cdc25B plays a significant role in the carcinogenesis and progression of renal cell carcinoma.
  • Targeting Cdc25B may represent a promising therapeutic strategy for RCC.
  • Further investigation into Cdc2B-based gene therapy for RCC is warranted.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...